Published in Stem Cells Transl Med on June 11, 2013
iPS cells: a game changer for future medicine. EMBO J (2014) 2.15
Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells. J Hepatol (2015) 1.74
Rethinking differentiation: stem cells, regeneration, and plasticity. Cell (2014) 1.41
Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity. Sci Rep (2017) 1.38
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods (2014) 1.08
Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med (2013) 1.07
Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes. Proc Natl Acad Sci U S A (2014) 1.04
High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Assay Drug Dev Technol (2013) 0.95
Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes. Stem Cell Reports (2015) 0.95
Modulating innate immunity improves hepatitis C virus infection and replication in stem cell-derived hepatocytes. Stem Cell Reports (2014) 0.89
Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs. Stem Cells Transl Med (2016) 0.87
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes. J Hepatol (2016) 0.82
Fluid shear stress modulation of hepatocyte-like cell function. Arch Toxicol (2016) 0.82
Modeling human liver biology using stem cell-derived hepatocytes. Int J Mol Sci (2013) 0.80
Pluripotent stem cells in neuropsychiatric disorders. Mol Psychiatry (2017) 0.80
New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells. Development (2015) 0.79
Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis. Assay Drug Dev Technol (2016) 0.78
The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases. Curr Protoc Toxicol (2016) 0.76
Application of Induced Pluripotent Stem Cells in Liver Diseases. Cell Med (2014) 0.76
Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment. J Clin Med (2014) 0.76
Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. J Mater Chem B Mater Biol Med (2016) 0.75
Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine. Stem Cells (2016) 0.75
Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells. Stem Cells Dev (2016) 0.75
Stabilizing hepatocellular phenotype using optimized synthetic surfaces. J Vis Exp (2014) 0.75
Xeno-sensing activity of the aryl hydrocarbon receptor in human pluripotent stem cell-derived hepatocyte-like cells. Sci Rep (2016) 0.75
Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor. Biores Open Access (2016) 0.75
Defined and Scalable Generation of Hepatocyte-like Cells from Human Pluripotent Stem Cells. J Vis Exp (2017) 0.75
Lipidomic profiling of patient-specific induced pluripotent stem cell-derived hepatocyte-like cells. Dis Model Mech (2017) 0.75
Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov (2004) 15.57
Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology (2010) 3.36
Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A (2008) 2.99
The future of drug development: advancing clinical trial design. Nat Rev Drug Discov (2009) 2.68
Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res (2010) 1.62
Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacology. Annu Rev Pharmacol Toxicol (2013) 1.10
The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation. Cell Reprogram (2010) 1.08
SUMOylation of HNF4α regulates protein stability and hepatocyte function. J Cell Sci (2012) 1.01
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest (2005) 8.58
An analysis of the feasibility of short read sequencing. Nucleic Acids Res (2005) 6.10
The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis (2008) 4.36
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med (2012) 3.96
Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology (2010) 3.36
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med (2013) 3.35
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis (2012) 3.16
Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A (2008) 2.99
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem (2002) 2.88
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol (2008) 2.83
Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A (2006) 2.75
Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol (2007) 2.64
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A (2012) 2.54
The bone marrow functionally contributes to liver fibrosis. Gastroenterology (2006) 2.52
Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology (2012) 2.52
Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology (2004) 2.44
Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871. Clin Cancer Res (2005) 2.31
Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology (2011) 2.27
Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells (2008) 2.20
Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med (2011) 2.15
Transcription forms and remodels supercoiling domains unfolding large-scale chromatin structures. Nat Struct Mol Biol (2013) 2.09
Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol (2003) 1.92
Amide bond formation: beyond the myth of coupling reagents. Chem Soc Rev (2008) 1.91
Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res (2004) 1.83
Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond) (2007) 1.77
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res (2011) 1.76
Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology (2005) 1.73
Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int (2004) 1.69
Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology (2011) 1.65
Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res (2010) 1.62
New fossil Lepidoptera (Insecta: Amphiesmenoptera) from the Middle Jurassic Jiulongshan Formation of Northeastern China. PLoS One (2013) 1.62
Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem (2004) 1.59
Is there a human homologue to the murine proteolysis-inducing factor? Clin Cancer Res (2007) 1.59
Modeling liver fibrosis in rodents. Methods Mol Med (2005) 1.57
Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect (2010) 1.57
Transcending scale dependence in identifying habitat with resource selection functions. Ecol Appl (2012) 1.56
A conserved Oct4/POUV-dependent network links adhesion and migration to progenitor maintenance. Curr Biol (2013) 1.54
Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol (2005) 1.53
Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo. Hepatology (2014) 1.52
Hepatic changes in the failing Fontan circulation. Heart (2006) 1.48
A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl (2002) 1.46
Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut (2010) 1.44
Decoding a PNA encoded peptide library by PCR: the discovery of new cell surface receptor ligands. Chem Biol (2011) 1.43
Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol (2011) 1.38
Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: The NIMH Multisite Acute HIV Infection Study: II. AIDS Behav (2009) 1.37
Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors. Mol Pharmacol (2005) 1.32
Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol (2009) 1.32
Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol (2003) 1.32
Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology (2011) 1.29
A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend (2002) 1.28
Palladium-mediated intracellular chemistry. Nat Chem (2011) 1.28
Post-translational modification by SUMO. Toxicology (2010) 1.26
Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score. Oncol Rep (2008) 1.24
Organotypic cultures as tools for functional screening in the CNS. Drug Discov Today (2005) 1.23
Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. J Hepatol (2006) 1.22
The relevance of a hypoxic tumour microenvironment in prostate cancer. BJU Int (2009) 1.22
Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci U S A (2013) 1.20
Persistence of functional hepatocyte-like cells in immune-compromised mice. Liver Int (2010) 1.18
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med (2010) 1.18
Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis (2006) 1.18
Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med (2007) 1.18
Snail family transcription factors are implicated in thyroid carcinogenesis. Am J Pathol (2007) 1.17
Reversibility of liver fibrosis. Ann Hepatol (2009) 1.16
Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa. Am J Trop Med Hyg (2009) 1.15
TNF-alpha induced DNA damage in primary murine hepatocytes. Int J Mol Med (2003) 1.15
Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol Sci (2012) 1.14
Polymer microarrays for cellular adhesion. Chem Commun (Camb) (2006) 1.13
CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. Cancer Res (2014) 1.12
CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J (2003) 1.11
Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacology. Annu Rev Pharmacol Toxicol (2013) 1.10
Peptides for cell-selective drug delivery. Trends Pharmacol Sci (2012) 1.10
The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment. Cloning Stem Cells (2008) 1.09
The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation. Cell Reprogram (2010) 1.08
The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. Clin Cancer Res (2008) 1.08
Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med (2013) 1.07
Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka. Trans R Soc Trop Med Hyg (2006) 1.05